Don’t miss the opportunity to apply for this great five-day programme at the European Centre for Disease Prevention and Control (ECDC) in Solna, Sweden. Application is open for Young Scientist ESCMID members and Full members 45 years old or younger. 

The ESCMID/ASM Conference on Drug Development will open abstract submission next week from 6 June until 27 June. Abstract submitters can also apply for attendance grants during this time as well. See the programme and learn more on the ESCMID website.

Registration for the ESCMID course on developing guidelines closes this week on 5 June.

The course taking place 15-17 September in Bologna, Italy is free of charge, but asks participants to send in a motivation letter to attend. See the programme and register today.

ESCMID has several onsite education courses that are available for registration now!

Review them all and register for the ones that pique your interest such as ‘Migration and Health: a world on the move’ or ‘Vaccination of the elderly in COVID-19 times’

The EMA has endorsed a joint statement by the ICMRA and the WHO to help healthcare professionals answer questions about the role of regulators in the oversight of COVID-19 vaccines and to reassure medical staff about the safety of vaccines that undergo a robust scientific evaluation.

We were pleased to host a late-breaking joint web symposium with IDSA covering the recent outbreak in Monkeypox in the EU and US with over 4,000 attendees! The recording is available for free on demand in the ESCMID eAcademy for those that could not attend live.

New drugs and methods to fight carbapenem-resistant Gram-negative pathogens are needed. This study characterized the preclinical PK/PD of the clinical-stage drug candidate apramycin. It shows modelling is a useful tool for inclusion of multiple data sources and simulation of expected scenarios.